HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Lu Selected Research

Cholesterol

9/2014Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safety.
4/2014MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
10/2011Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis.
12/2008Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases.
2/2008Xenobiotic transporters: ascribing function from gene knockout and mutation studies.
12/2002Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Lu Research Topics

Disease

87Neoplasms (Cancer)
02/2024 - 04/2002
85Infections
05/2024 - 04/2004
41Inflammation (Inflammations)
04/2024 - 11/2005
26Atherosclerosis
11/2018 - 12/2004
25Breast Neoplasms (Breast Cancer)
07/2023 - 01/2008
17Neoplasm Metastasis (Metastasis)
01/2023 - 01/2010
15Abdominal Aortic Aneurysm
02/2019 - 02/2007
13Uveitis
01/2023 - 01/2009
12Fibrosis (Cirrhosis)
04/2022 - 01/2014
11Stomach Neoplasms (Stomach Cancer)
11/2023 - 04/2005
11Stroke (Strokes)
10/2023 - 01/2010
10Wounds and Injuries (Trauma)
04/2024 - 10/2002
10Pain (Aches)
03/2024 - 01/2005
10Carcinogenesis
01/2024 - 12/2008
10Ischemic Stroke
06/2022 - 01/2016
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 06/2011
9Parkinson Disease (Parkinson's Disease)
05/2024 - 01/2016
9Lung Neoplasms (Lung Cancer)
01/2024 - 06/2007
8Brain Edema (Cerebral Edema)
12/2023 - 07/2012
8Carcinoma (Carcinomatosis)
01/2018 - 04/2002
7Hepatocellular Carcinoma (Hepatoma)
11/2023 - 11/2011
7Hemorrhage
11/2023 - 08/2005
7Thrombosis (Thrombus)
01/2022 - 01/2010
7Hypoxia (Hypoxemia)
01/2022 - 08/2005
7Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 08/2011
7Glaucoma
11/2020 - 01/2011
7Cataract (Cataracts)
01/2020 - 01/2009
7Rheumatoid Arthritis
09/2014 - 01/2009
6Lacerations
03/2024 - 02/2023
6COVID-19
03/2024 - 06/2020
6Esophageal Neoplasms (Esophageal Cancer)
10/2019 - 11/2003
6Rupture
02/2019 - 01/2009
6Aortic Aneurysm (Aneurysm, Aortic)
11/2015 - 12/2011
6Anterior Uveitis
12/2013 - 08/2010
5Neuroinflammatory Diseases
05/2024 - 01/2020
5Edema (Dropsy)
11/2023 - 07/2012
5Pancreatic Neoplasms (Pancreatic Cancer)
07/2023 - 08/2006
5Reperfusion Injury
05/2023 - 08/2014
5Infarction (Infarctions)
10/2021 - 01/2016
5Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2021 - 11/2011
5Ureteral Obstruction
12/2019 - 06/2014
5Alzheimer Disease (Alzheimer's Disease)
09/2019 - 06/2012
5Hypercholesterolemia
01/2018 - 12/2004
4Liver Diseases (Liver Disease)
04/2024 - 06/2019
4Squamous Cell Carcinoma of Head and Neck
02/2024 - 02/2009
4Virus Diseases (Viral Diseases)
12/2023 - 01/2013
4Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 04/2012
4Necrosis
05/2023 - 10/2011

Drug/Important Bio-Agent (IBA)

56Proteins (Proteins, Gene)FDA Link
04/2024 - 04/2002
20Biomarkers (Surrogate Marker)IBA
09/2023 - 02/2005
18Angiotensin IIIBA
02/2019 - 02/2007
16CytokinesIBA
04/2024 - 08/2010
16Messenger RNA (mRNA)IBA
01/2023 - 02/2005
15MicroRNAs (MicroRNA)IBA
01/2023 - 12/2008
14Peptides (Polypeptides)IBA
10/2021 - 12/2004
13EndotoxinsIBA
01/2023 - 01/2009
11DNA (Deoxyribonucleic Acid)IBA
01/2024 - 12/2002
10Interleukin-6 (Interleukin 6)IBA
02/2024 - 10/2005
10Amoxicillin (Wymox)FDA LinkGeneric
08/2020 - 10/2013
10Lipoproteins (Lipoprotein)IBA
08/2015 - 06/2009
9Transcription Factors (Transcription Factor)IBA
11/2023 - 03/2007
9EnzymesIBA
11/2023 - 08/2005
9BismuthIBA
08/2020 - 07/2013
9LDL Receptors (LDL Receptor)IBA
02/2016 - 12/2002
8LipidsIBA
02/2024 - 04/2014
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2023 - 06/2008
8LipopolysaccharidesIBA
01/2023 - 01/2009
8Indicators and Reagents (Reagents)IBA
04/2022 - 10/2015
7Retinaldehyde (Retinal)IBA
03/2024 - 01/2009
7Long Noncoding RNAIBA
02/2024 - 01/2018
7Levofloxacin (Levaquin)FDA Link
04/2023 - 08/2011
7Interleukin-10 (Interleukin 10)IBA
01/2022 - 08/2010
7NF-kappa B (NF-kB)IBA
01/2018 - 03/2007
6Glucose (Dextrose)FDA LinkGeneric
04/2024 - 11/2004
6Toll-Like Receptors (Toll-Like Receptor)IBA
02/2024 - 01/2011
6Metronidazole (Metric)FDA LinkGeneric
04/2023 - 07/2013
6Therapeutic UsesIBA
01/2023 - 01/2005
6ResveratrolIBA
04/2022 - 04/2010
6Clarithromycin (Biaxin)FDA LinkGeneric
01/2021 - 07/2013
6Polysaccharides (Glycans)IBA
01/2018 - 06/2005
6Matrix Metalloproteinases (MMPs)IBA
05/2017 - 08/2014
6CholesterolIBA
09/2014 - 12/2002
6Antiviral Agents (Antivirals)IBA
07/2013 - 04/2006
6Anti-Infective Agents (Microbicides)IBA
01/2013 - 05/2005
5Small Interfering RNA (siRNA)IBA
02/2024 - 07/2012
5Hemoglobins (Hemoglobin)IBA
11/2023 - 01/2018
5Particulate MatterIBA
10/2023 - 01/2018
5Toll-Like Receptor 4IBA
01/2012 - 01/2009
4InflammasomesIBA
05/2024 - 05/2017
4ChemokinesIBA
04/2024 - 01/2014
4Fatty Acids (Saturated Fatty Acids)IBA
04/2024 - 01/2014
4AntioxidantsIBA
01/2024 - 06/2016
4Urea (Carbamide)FDA LinkGeneric
04/2023 - 01/2016
4Esomeprazole (Nexium)FDA Link
04/2023 - 01/2019
4Immunoglobulin G (IgG)IBA
03/2023 - 12/2006

Therapy/Procedure

49Therapeutics
12/2023 - 11/2004
18Drug Therapy (Chemotherapy)
01/2023 - 08/2005
8Episiotomy
03/2024 - 08/2020
6Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2023 - 01/2005
4Neoadjuvant Therapy
07/2023 - 01/2022